Vetinnova
PORTAL DE REFERENCIA SOBRE I+D+i
EN SANIDAD ANIMAL
 

Área Personal

Acceso al área privada de la web
Búsqueda de texto en la web

fbus

CREA TU PERFIL Grupo de Investigación
Grupo de Investigación
CREA TU PERFIL Empresa
Empresa

 Safe, effective and oral antiparasitics against protozoal infections

The purine nucleoside platform is based on known and novel sugar- and purine ring scaffolds. The nucleoside platform contains lead molecules for different indications. Proof of concept data at different stages (in vitro to in vivo) are available for various indications: Leishmania, Chagas, Nagana disease, Dourine, Surra, Blackhead, Cryptosporidium, and Toxoplasma species. Proof of concept in various mouse models As an example, we found 3’-deoxytubercidin analogues to be highly potent trypanocides against T. brucei spp. One analogue served as proof-of-concept in relevant mouse model of T. brucei infection. This derivative, 3’-deoxytubercidin, displays curative activity in both acute and CNS-stage infection in mice, highlighting that it is able to cross the blood-brain-barrier, likely a class effect.
A purine nucleoside platform with the ability to act as antiprotozoal agents
· Nombre de contacto Sven Arnouts
· Correo electrónico sven.arnouts@ugent.be
· Teléfono +32 495 707 334
· Socio buscado Partnering We seek development and marketing partners interested in developing nucleoside analogues as anti-parasitic against protozoal infections.

Sven Arnouts
sven.arnouts@ugent.be
+32 495 707 334

Una iniciativa de

Vet + i
Vetdivulga
Ayuda PTR2022-001249 financiada por:

UNION EUROPEA - FONDO EUROPEO DE DESARROLLO REGIONAL